[144] Plexus Corp SEC Filing

Rhea-AI Filing Summary

Plexus Corporation (PLXS) Form 144: A notice of proposed sale reports 2,102 common shares to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 08/15/2025. The filing lists an aggregate market value of $274,163.86 and 26,986,726 shares outstanding. The shares were acquired as performance shares on 11/16/2023 from the issuer and were fully paid on that date. The filer reports no securities sold in the past three months. The notice includes the standard signer representation that the selling person is not aware of any undisclosed material adverse information about the issuer.

Positive

• Full transaction details disclosed: class, broker, number of shares, aggregate value, and approximate sale date are all provided
• Acquisition origin specified: shares were granted as performance shares and acquired on 11/16/2023
• No recent dispositions: filer reports nothing to report for securities sold in the past three months

Negative

• None.

Insights

Securities Analyst

TL;DR: Form 144 discloses a small proposed sale of 2,102 performance shares worth $274k, filed for sale through Morgan Stanley on NASDAQ.

The filing is routine: it identifies the broker, the class, the acquisition date and nature (performance shares), the proposed approximate sale date, aggregate market value and total shares outstanding. There are no reported sales in the prior three months, which indicates this is a new planned disposition rather than a follow-up sale. Materiality appears limited given the disclosed size, and the form includes the required representation regarding undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Governance disclosure standards met: acquisition details and broker are provided; filer affirms no undisclosed material information.

The Form 144 provides the key compliance elements: nature and date of acquisition (performance shares on 11/16/2023), proposed broker and sale date, and the seller's legal attestation. The relationship to the issuer field is present but not populated in the provided text. No information in the filing suggests a governance violation; the notice follows Rule 144 procedural requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2102	274163.86	26986726	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/16/2023	Performance Shares	Issuer			2102	11/16/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Plexus (PLXS) Form 144 report?

The filing reports a proposed sale of 2,102 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/15/2025 and aggregate market value of $274,163.86.

When and how were the shares being sold acquired?

The 2,102 shares were acquired as performance shares from the issuer on 11/16/2023, with payment recorded as of that date.

Does the Form 144 show prior sales by the same person?

No; the filing states Nothing to Report for securities sold during the past three months.

Which broker and exchange are listed for the proposed sale?

The broker is Morgan Stanley Smith Barney LLC and the securities exchange is listed as NASDAQ.

Does the filer assert any undisclosed material information about Plexus?

By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.